Ronit Aloni-Grinstein and Shahar Rotem. COVID-19 Pandemic: A Lesson for Antibiotic and Antiseptic Stewardship.
. 2021; 9(2):48-51. doi: 10.12691/AJPHR-9-2-1
antibiotic stewardship, antiseptic stewardship, COVID-19, SAR-CoV-2, pandemic
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | WHO. Pneumonia of unknown cause-China. 2020; Available from: who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/. |
|
[2] | Coronaviridae Study Group of the International Committee on Taxonomy of, V., The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol, 2020. 5(4): p. 536-544. |
|
[3] | 2020; Available from: worldometers.info/coronavirus/. |
|
[4] | Dhama, K., et al., Coronavirus disease 2019-COVID-19. Clinical Microbiology Reviews, 2020. 33(4): p. e00028-20. |
|
[5] | Wang, D., et al., Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020. 323(11): p. 1061-1069. |
|
[6] | Chen, N., et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 2020. 395(10223): p. 507-513. |
|
[7] | Keni, R., et al., COVID-19: Emergence, Spread, Possible Treatments and Global Burden. Front. Public Health, 2020. |
|
[8] | Shen, C., et al., Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA, 2020. 323: p. 1582-1589. |
|
[9] | Noy-Portat, T., et al., A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes. Nature Communications, 2020. 11: p. 4303. |
|
[10] | COVID-19-List results-ClinicalTrials.gov.; Available from: https://www.clinicaltrials.gov/ct2/results?cond=COVID- 19&term=&state=&city=7dist. |
|
[11] | Maclntyre, C.R., et al., The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a (H1N1)pdmo9. BMC Infect Dis., 2018. 18(1): p. 637. |
|
[12] | Vaughn, V.M., et al., Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: A multi-hospital cohort study. Clin Infect Dis, 2020: p. ciaa1239. |
|
[13] | Sepulveda, J., et al., Bacteremia and blood culture utilization during COVID-19 surge in New York city. Journal of Clinical Microbiology, 2020: p. 58e00875-20. |
|
[14] | Lansbury, L., et al., Co-infection in people with COVID-19: a systemic review and meta-analysis. Journal of Infection and Chemotherapy., 2020. |
|
[15] | Langford, B.J., et al., Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection, 2020. |
|
[16] | Hutter, B.D., et al., COVID-19: don't neglect antimicrobial stewardship principles! Clinical Microbiology and Infection, 2020. |
|
[17] | Zhou, F., et al., Clinical course and risk facors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 2020. 395(10229): p. 1054-1062. |
|
[18] | Cox, M., et al., Co-infection: potentiallly lethal and unexplored in COVID-19. The Lancet, 2020. 1. |
|
[19] | Clancy, C.J. and M.H. Nguyen, Coronavirus disease 2019, Superinfections and antimicrobial development: What can we expect? Clin Infect Dis, 2020. |
|
[20] | Clancy, C.J., D.J. Buehrle, and M.H. Nguyen, Pro: The COVID-19 pandemic will result in increase in animicrobial resistance rates. JAC Antimicrob Resist, 2020. |
|
[21] | WHO, Clinical management of COVID-19 Interim guidance. 2020. |
|
[22] | CDC. Community, Work and Schools: Cleaning and Disinfecting 2020; Available from: cdc.gov/coronavirus/2019-ncov/community/clean-disinfect/index/html. |
|
[23] | Hora, P.I., et al., Increase use of quaternary ammonium compounds during the SARS-CoV-2 pandemic and beyond: considereation of environmetal implications. 2020. |
|
[24] | EPA. List N tools: COVID-19 Disinfectants. 2020; Available from: cfpub.epa.gov/giwiz/disinfectants/index/cfm. |
|
[25] | Wales, A.D. and R.H. Davis, Co-selection of resistance to antibiotics, biocides and heavy metals, and its relevance to foodborne pathogens. Antibiotics, 2015. 4: p. 567-604. |
|
[26] | Nordmann, P., et al., The emerging NDM carbapenemases. Trends in Microbiology, 2011. 19(12): p. 588-595. |
|
[27] | Castanheira, M., et al., Detection of mcr-1 among Escherichia coli clinical isolates collected worldwide as part of the sentry antimicrobial surveillance program in 2014 and 2015. Antimicrob Agents Chemother., 2016. 60(22): p. 5623-4. |
|
[28] | Rawson, T.M., et al., COVID-19 and the potential long-term impact on antimicrobial resistance. Journal of Antimicrobial Chemotherapy, 2020. |
|
[29] | Getahun, H., et al., Tackling antimicrobial resistance in the COVID-19 pandemic. Bulletin of the World Health Organization, 2020. 98: p. 442-442A. |
|